Academic Journal
Q4Epilepsy and Paroxysmal Conditions
About Epilepsy and Paroxysmal Conditions
Epilepsy and Paroxysmal Conditions is a scholarly journal published by IRBIS LLC. SCImago 2025 lists it in Q4, with an SJR of 0.25 and H-index of 7.
Coverage: 2017-2025. Research categories: Neurology (Q4); Neurology (clinical) (Q4).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2022-10-23. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Epilepsy research and treatment; Pharmacological Effects and Toxicity Studies; Neuroscience and Neuropharmacology Research; Genetics and Neurodevelopmental Disorders; Metabolism and Genetic Disorders; EEG and Brain-Computer Interfaces.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Pharmacogenomics and pharmacometabolomics of levetiracetam in personalized neurotoxicity risk assessment
N. A. Shnayder, V. V. Bader, N. A. Pekarets, Yu. N. Bykov et al.
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.274Beyond consensus: expert assessment of epilepsy pharmacotherapy through the lens of multi-level verification
A. S. Romanov, E. F. Sharakhova
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.276Intrafamilial clinical polymorphism of CACNA1A-related disorders
A. G. Malov, T. P. Kalashnikova, O. I. Tsymbal
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.268The relationship between electroencephalography characteristics and intellectual development indicators in self-limited focal childhood epilepsy (pilot study)
M. S. Maslov, A. A. Kholin, N. N. Zavadenko
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.273Gas chromatography-mass spectrometry for quantitating valproic acid in blood serum
V. M. Bannikova, A. A. Seidkulieva, Yu. M. Panov, I. D. Kargin et al.
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.275The evolution of the publishing strategy and its effect on the journal's bibliometric performance
D. V. Blinov
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.288Preictal warning phenomena in focal epilepsy
E. A. Narodova, V. V. Narodova, E. E. Erakhtin
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.272Practical recommendations for EEG room organization
A. A. Ivanov
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.270On the 80th anniversary of Professor Gagik Norayrovich Avakyan’s birth (1946–2019): a life dedicated to neurology and epilepsy
D. V. Blinov, G. G. Avakyan
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.290Ictal, postictal and interictal autonomic disturbances in patients with focal epilepsy
M. Yu. Maximova, A. G. Broutian, E. A. Berestova
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.279Epilepsy in young children: a retrospective study of patient profiles
L. B. Novikova, K. M. Ziultsle, A. P. Akopyan, N. M. Faizullina et al.
2026-08-03 · DOI: 10.17749/2077-8333/epi.par.con.2026.262Prevalence of clinical manifestations of metabolic syndrome in patients with epilepsy treated with antiepileptic drugs (a pilot study)
N. A. Pekarets, N. A. Shnayder, V. A. Mikhailov, S. A. Korovina et al.
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.255The analysis and interpretation of trajectories and patterns of autism symptom development in children
L. O. Tkacheva, A. D. Nasledov, O. V. Zashchirinskaia, S. A. Miroshnikov et al.
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.259Triggers of reflex epilepsy
N. N. Maslova, M. N. Geraskina, N. V. Yuryeva, A. N. Postyleva et al.
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.266A new twist in the story of neurochemical communication: co-transmission
S. Narwal, S. Arora, P. Kumari, T. Dandha et al.
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.233Rare levetiracetam-related adverse events in treatment of epilepsy
T. V. Melashenko, Z. G. Tadtaeva, A. N. Galustyan, N. A. Galankin et al.
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.258Cloud technologies and telemedicine in electroencephalography
A. A. Ivanov
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.260Early provoking factors of epileptogenesis in mesial temporal lobe epilepsy
A. S. Kotov, К. V. Firsov
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.264The role of multiphasic personality questionnaires in the diagnosis of dissociative disorders in patients with epilepsy
M. V. Guseva, N. A. Sivakova, O. N. Yakunina, V. A. Mikhailov et al.
2026-04-25 · DOI: 10.17749/2077-8333/epi.par.con.2026.256The possibilities of video-electroencephalographic monitoring in diagnostics of chronic post-anoxic myoclonus in children: a pilot study
D. S. Kanshina, D. V. Vasileva, E. F. Mikhnevich, A. A. Troitskiy et al.
2026-01-15 · DOI: 10.17749/2077-8333/epi.par.con.2025.241Reviews
Community Reviews
Version History
October 2, 2026 at 10:16 pm
October 2, 2026